2297 — Rainmed Medical Cashflow Statement
0.000.00%
- HK$332.82m
- HK$152.66m
- CNY39.82m
Annual cashflow statement for Rainmed Medical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -151 | -639 | -1,351 | -117 | -116 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 118 | 563 | 1,222 | -4.57 | 15.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 32.9 | -8.11 | 2 | -24.9 | -6.77 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2.27 | -72.8 | -111 | -124 | -84.3 |
| Capital Expenditures | -4.04 | -31.1 | -29.8 | -111 | -53.8 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 12.7 | 3.13 | -486 | 291 | 60.1 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 8.69 | -28 | -516 | 180 | 6.31 |
| Financing Cash Flow Items | -0.179 | -9.84 | -17.7 | -0.939 | -0.766 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.53 | 634 | 121 | -15.9 | 0.723 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 20.5 | 532 | -468 | 43 | -79.5 |